Danaher Says AB Sciex Integration Going 'Very Well,' Hints of Launches at ASMS | GenomeWeb

This story originally ran on April 22.

By Tony Fong

Danaher's recent acquisitions of AB Sciex and Molecular Devices helped grow sales for its life science and diagnostic business 52 percent in the first quarter year over year, the company said this week.

The three months ended April 2 represented the conglomerate's first quarter as the owner of the mass spec business once jointly controlled and operated by Life Technologies and MDS.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.